Bionano Genomics (BNGO) Change in Account Payables (2017 - 2026)
Bionano Genomics (BNGO) reported Change in Account Payables of -$528000.0 for Q1 2026, down 31.67% on a YoY basis from -$772729.9 in Q1 2025, and down 32.33% sequentially from -$399000.0 in Q4 2025.
Bionano Genomics (BNGO) Change in Account Payables (2017 - 2026) Analysis & Trends
Bionano Genomics (BNGO) has 10 years of Change in Account Payables data on file, last reported at -$528000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 31.67% year-over-year to -$528000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.5 million (up 54.35% YoY), and the FY2025 full-year result was -$1.4 million, up 59.88% from the prior year.
- Change in Account Payables declined to -$528000.0 in Q1 2026, from -$399000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.2 million in Q3 2023 to a low of -$4.4 million in Q4 2023.
- A 5-year average of -$315647.1 and a median of -$399000.0 in 2025 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables surged 280.0% in 2023 and sank 719.35% in 2025, its largest moves.
- Tracing BNGO's Change in Account Payables over 5 years: stood at $3.2 million in 2022, then slumped by 238.15% to -$4.4 million in 2023, then soared by 60.4% to -$1.7 million in 2024, then jumped by 77.08% to -$399000.0 in 2025, then tumbled by 32.33% to -$528000.0 in 2026.
- Business Quant data shows BNGO's Change in Account Payables at -$528000.0 in Q1 2026, -$399000.0 in Q4 2025, and -$254000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 6.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -100.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 4.93 Mn |
| 10 | Bionano Genomics | 4.34 Mn | -9.35 Mn | 3.25 Mn | -528,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -528,000.00 |
| Mar 31, 2026 | -528,000.00 |
| Dec 31, 2025 | -399,000.00 |
| Dec 31, 2025 | -399,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Jun 30, 2025 | -318,000.00 |
| Jun 30, 2025 | -318,000.00 |
| Mar 31, 2025 | -401,000.00 |
| Mar 31, 2025 | -401,000.00 |
| Dec 31, 2024 | -1.74 Mn |
| Dec 31, 2024 | -1.74 Mn |
| Sep 30, 2024 | -31,000.00 |
| Sep 30, 2024 | -31,000.00 |
| Jun 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | -537,000.00 |
| Mar 31, 2024 | -537,000.00 |
| Dec 31, 2023 | -4.40 Mn |
| Dec 31, 2023 | -4.40 Mn |